CN101492439A - Dihydromyricetin-3-carboxylic ester and preparation method thereof - Google Patents

Dihydromyricetin-3-carboxylic ester and preparation method thereof Download PDF

Info

Publication number
CN101492439A
CN101492439A CN 200910037329 CN200910037329A CN101492439A CN 101492439 A CN101492439 A CN 101492439A CN 200910037329 CN200910037329 CN 200910037329 CN 200910037329 A CN200910037329 A CN 200910037329A CN 101492439 A CN101492439 A CN 101492439A
Authority
CN
China
Prior art keywords
dibydro myricetrin
carboxylicesters
preparation
acid
dibydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200910037329
Other languages
Chinese (zh)
Inventor
严赞开
胡春菊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanshan Normal University
Original Assignee
Hanshan Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanshan Normal University filed Critical Hanshan Normal University
Priority to CN 200910037329 priority Critical patent/CN101492439A/en
Publication of CN101492439A publication Critical patent/CN101492439A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to dihydromyricetin-3-carboxylic ester with a structural general formula , wherein R is fatty acid acyl or aromatic acid acyl containing 1-7 carbon atoms. The dihydromyricetin-3-carboxylic ester has oxidation resistance obviously superior to that of dihydromyricetin, has good stability, can be used in the fields of food, medicine, feed and the like, and has wide market development prospect. The invention also relates to a preparation method of the dihydromyricetin-3-carboxylic ester, which has the advantages of simplicity, convenience, practicability, high yield, low cost and the like and is easy to realize industrial production.

Description

Dibydro myricetrin-3-carboxylicesters and preparation method thereof
Technical field
The present invention relates to dibydro myricetrin-3-carboxylicesters and preparation method thereof.
Background technology
Dibydro myricetrin (3,5,7,3 ', 4 ', 5 '-hexahydroxy--2, the 3-flavanonol dihydromyricetin), has another name called two hydrogen ampelopsin, belongs to the flavanone alcohol compound, is present in the ampelopsis in a large number.This compound first by Kotake and Kubota in 1940 from Vitaceae ampelopsis fujian tea, promptly separate obtaining called after ampelopsin (ampelopsin) in the leaf of A. Meliaefolia (A.Meliaefolia).The dibydro myricetrin structural formula is as follows:
Figure A20091003732900041
Dibydro myricetrin has tangible antioxygenation.Under the situation of equal addition, its antioxidant property can reach even surpass present chemosynthesis antioxidant TBHQ (see poplar book treasure etc., Chinese oil, 2003, (1): 44~46 and Zhang Yousheng etc., medicine journal, 2003,38 (4): 241~244).
Yet dihydromyricetin prime system polarity compounds is insoluble in grease compound system, if to joining in the grease after its emulsification, can constantly separate out from product along with the variation of time again, thereby has limited the application of dibydro myricetrin.Therefore need transform the dibydro myricetrin chemical structure and solve the problem that it is insoluble in oil, but reach both prolonged preservation, have better antioxidation again.
Modern scientific research finds that the oxidation-resistance of flavonoid compound depends on hydroxy position and degree of hydroxylation, and a lot of equal hydroxyls of material show different oxidation-resistances with hydroxyl number and position difference.Studies show that in a large number 3 ', 4 ', 5 ' hydroxyl on the dibydro myricetrin is main reactive site anti-oxidant, that remove free radical, wherein 4 ' hydroxyl is the strong anti-oxidation base, and promptly strong active group is the strong and weak primary factor of decision oxidation-resistance; 5 hydroxyls, 7 hydroxyls help antioxygenic activity, to anti-oxidant synergism; And 3 hydroxyls should (be seen Zhang Hongyu, Chinese science (B), 1999,29 (1): 91~96) to oxidation-resistance is invalid.
The chemically modified of dibydro myricetrin is by carboxylic acid halides and dibydro myricetrin direct esterification at present, change its fat-soluble relatively poor weakness, but in the reaction process often in conjunction with or shielded dibydro myricetrin main anti-oxidant functional group--phenolic hydroxyl group (is seen Guo Qingquan etc., Food science, 2006,27 (5): 21~23).
The Chinese patent publication number is CN200410026610.5, open day is on September 28th, 2005, the name of innovation and creation is called the preparation method of dibydro myricetrin fatty acid ester, it is raw material that this application discloses with the dibydro myricetrin, under alkaline condition,, prepare the method for dibydro myricetrin fatty acid ester with the effect of lipid acid carboxylic acid halides.Use this synthetic method, the dibydro myricetrin phenolic hydroxyl group is than the preferential formation ester of alcoholic extract hydroxyl group, and promptly 5,7,3 ', 4 ', 5 ' hydroxyl easily forms ester than 3 hydroxyls.When dibydro myricetrin and lipid acid carboxylic acid halides ratio were less than or equal to 1: 5, fatty acyl group formed mono fatty acid ester or many fatty acid ester at 5,7,3 ', 4 ', 5 '; When dibydro myricetrin and lipid acid carboxylic acid halides ratio during, then form ester simultaneously at 5,7,3 ', 4 ', 5 ' and 3 more than or equal to 1: 6.
Dibydro myricetrin after chemically modified though increased fat-solublely, helps antioxidant effect; But because esterification, combine the antioxygenic activity group, thereby reduced the resistance of oxidation of material itself, therefore the essentially no variation of antioxygenic activity of the dibydro myricetrin before and after the modification (is seen Zhang Yousheng etc., research and development of natural products, 2006, (18): 260~262 and Li Wei etc., Food science, 2005,26 (9): 73~76).
Summary of the invention
The objective of the invention is in order to overcome deficiency of the prior art, providing a kind of had both had good fat-solublely, had dibydro myricetrin-3-carboxylicesters of strong antioxygenic activity and preparation method thereof again.
The invention provides a kind of dibydro myricetrin-3-carboxylicesters, have general structure (I):
Wherein, R is fatty acid acyl or the aromatic acid acyl group that contains 1~7 carbon atom.
Dibydro myricetrin of the present invention-3-carboxylicesters, the preferred formyl radical of described fatty acid acyl, ethanoyl, propionyl, butyryl radicals, pentanoyl, caproyl or oenanthyl.
Dibydro myricetrin of the present invention-3-carboxylicesters, the preferred galloyl of described aromatic acid acyl group, salicyloyl, benzoyl, para hydroxybenzene formyl radical, protocatechuoyl, vanilloyl, coffee acyl, cinnamoyl, to hydroxyl cinnamoyl, asafoetide acyl group, different asafoetide acyl group or green former acyl group.
The preparation method of dibydro myricetrin of the present invention-3-carboxylicesters may further comprise the steps:
Dibydro myricetrin is mixed than 1: 1~3 by amount with complexing agent; be dissolved in the inert organic solvents at 60~80 ℃; the aliphatic or aromatic acid that adds 1.2~1.8 times of dibydro myricetrin amounts then adds catalyzer again, reacts under nitrogen protection; temperature of reaction is 80~120 ℃; reaction times is 4~12h, and the pressure reducing and steaming solvent is used ethyl alcohol recrystallization; drying makes dibydro myricetrin-3-carboxylicesters.This method preparation dibydro myricetrin-3-carboxylicesters productive rate can be up to 60~82%.
The preparation method of dibydro myricetrin of the present invention-3-carboxylicesters, described complexing agent preferred boric acid.
The preparation method of dibydro myricetrin of the present invention-3-carboxylicesters, described inert organic solvents is preferred 1,4-dioxane, methyl-sulphoxide, N, one or more arbitrary proportions in dinethylformamide, the hexanaphthene mix.
The preparation method of dibydro myricetrin of the present invention-3-carboxylicesters, one or more arbitrary proportions in the preferred sulfonic compound of described catalyzer mix.
The preparation method of dibydro myricetrin of the present invention-3-carboxylicesters, the preferred tosic acid of described sulfonic compound, Phenylsulfonic acid or thionamic acid.
Dibydro myricetrin of the present invention-3-carboxylicesters is on the one hand because esterification obtains good fat-soluble, on the other hand because the carboxylic acid bonded is to invalid 3 alcoholic extract hydroxyl groups of answering of oxidation-resistance on the dibydro myricetrin, the phenolic hydroxyl group that antioxygenic activity is stronger has been retained, thereby improved antioxygenic activity, the resistance of oxidation that obviously is better than dibydro myricetrin, and have satisfactory stability, can be used for fields such as food, medicine and feed, have brilliant market developing prospect.
The preparation method of dibydro myricetrin of the present invention-3-carboxylicesters, have easy, practical, productive rate is high, low cost and other advantages, is easy to realize suitability for industrialized production.
Embodiment
Below by embodiment the present invention is done further specific descriptions, but embodiments of the present invention are not limited thereto.
The preparation of embodiment 1. dibydro myricetrins-3-gallic acid ester
Get dibydro myricetrin 3.20g (10mmol), boric acid 1.24g (20mmol) is dissolved in 100mL 1 under 70 ℃; in the 4-dioxane, add gallic acid 2.40g (14mmol) then, tosic acid 0.50g (3mmol); under nitrogen protection, react; temperature is 105 ℃, insulation backflow 8h, pressure reducing and steaming solvent; use ethyl alcohol recrystallization; drying gets solid dibydro myricetrin-3-gallic acid ester 3.86g, and productive rate is 81.86%.
The preparation of embodiment 2. dibydro myricetrins-3-gallic acid ester
Get dibydro myricetrin 3.20g (10mmol), boric acid 1.24g (20mmol) is dissolved under 70 ℃ in the 100mL hexanaphthene; add gallic acid 2.40g (14mmol) then, tosic acid 0.50g (3mmol), assembling water trap; nitrogen protection is fully stirred, and temperature is 95 ℃; insulation backflow 6h; cooled and filtered is used ethyl alcohol recrystallization, drying; get solid dibydro myricetrin-3-gallic acid ester 3.31g, productive rate is 70.20%.
The preparation of embodiment 3. dibydro myricetrins-3-acetic ester
Get dibydro myricetrin 3.20g (10mmol), boric acid 1.24g (20mmol) is dissolved in 100mL 1 under 70 ℃; in the 4-dioxane, add glacial acetic acid 0.84g (14mmol) then, tosic acid 0.50g (3mmol); under nitrogen protection, react; temperature is 105 ℃, insulation backflow 6h, pressure reducing and steaming solvent; use ethyl alcohol recrystallization; drying gets solid dibydro myricetrin-3-acetic ester 2.25g, and productive rate is 62.15%.
Comparative Examples 1. dibydro myricetrins-3-carboxylicesters and the anti-oxidant test of dibydro myricetrin carboxylicesters
Be that the described method of patent application of CN200410026610.5 prepares dibydro myricetrin-3-carboxylicesters, the dibydro myricetrin carboxylicesters is to be measured by the present invention and Chinese patent publication number respectively, in the dibydro myricetrin carboxylicesters preparation process ratio of dibydro myricetrin and carboxylic acid halides be divided into 1: 1 and 1: 6 two kinds.With blank sample, 2,6 ditertiary butyl p cresol (BHT), dibydro myricetrin is control sample, carries out anti-oxidant test according to the following steps respectively:
Take by weighing lard 25g, add the sample of 0.01g, fully mixing is placed in 70 ℃ of constant temperature vibrating bins heat tracing in the water-bath.Accurately take by weighing 2g lard every 48h, place the iodine flask of 250mL, add 25mL trichloromethane-glacial acetic acid (V Glacial acetic acid: V Chloroform=3: 2) mixed solution dissolves lard fully.Add the 1.00mL saturated solution of potassium iodide, closely filled in bottle cap, and jolting 0.5min gently, 5min in the dark placed then.Taking-up adds 100mL water, shakes up, and uses 2 * 10 at once -3MolL -1The sodium thiosulfate standard solution titration adds the 1mL Starch Indicator to faint yellow, continues titration to blue the disappearance and is terminal point.Experimental result sees Table 1.
The experimental result of table 1 shows that the antioxygenic activity of dibydro myricetrin-3-carboxylicesters is better than dibydro myricetrin, 2,6-ditertbutylparacresol (BHT), also being better than by the Chinese patent publication number is the described method synthetic of the patent application dibydro myricetrin carboxylicesters of CN200410026610.5.
The POV value (peroxide value) of the anti-oxidant test of table 1 sample
Figure A20091003732900091
Figure A20091003732900101

Claims (8)

1, dibydro myricetrin-3-carboxylicesters has general structure (I):
Wherein, R is fatty acid acyl or the aromatic acid acyl group that contains 1~7 carbon atom.
2, the described dibydro myricetrin of claim 1-3-carboxylicesters is characterized in that, described fatty acid acyl is formyl radical, ethanoyl, propionyl, butyryl radicals, pentanoyl, caproyl or oenanthyl.
3, the described dibydro myricetrin of claim 1-3-carboxylicesters; it is characterized in that described aromatic acid acyl group is galloyl, salicyloyl, benzoyl, para hydroxybenzene formyl radical, protocatechuoyl, vanilloyl, coffee acyl, cinnamoyl, to hydroxyl cinnamoyl, asafoetide acyl group, different asafoetide acyl group or green former acyl group.
4, the preparation method of the described dibydro myricetrin of claim 1-3-carboxylicesters is characterized in that, may further comprise the steps:
Dibydro myricetrin is mixed than 1: 1~3 by amount with complexing agent; be dissolved in the inert organic solvents at 60~80 ℃; the aliphatic or aromatic acid that adds 1.2~1.8 times of dibydro myricetrin amounts then adds catalyzer again, reacts under nitrogen protection; temperature of reaction is 80~120 ℃; reaction times is 4~12h, and the pressure reducing and steaming solvent is used ethyl alcohol recrystallization; drying makes dibydro myricetrin-3-carboxylicesters.
5, the preparation method of the described dibydro myricetrin of claim 4-3-carboxylicesters is characterized in that described complexing agent is a boric acid.
6, the preparation method of the described dibydro myricetrin of claim 4-3-carboxylicesters is characterized in that described inert solvent is 1,4-dioxane, methyl-sulphoxide, N, and one or more arbitrary proportions in dinethylformamide, the hexanaphthene mix.
7, the preparation method of the described dibydro myricetrin of claim 4-3-carboxylicesters is characterized in that, described catalyzer is that one or more arbitrary proportions in the sulfonic compound mix.
8, the preparation method of the described dibydro myricetrin of claim 7-3-carboxylicesters is characterized in that, described sulfonic compound is tosic acid, Phenylsulfonic acid or thionamic acid.
CN 200910037329 2009-02-18 2009-02-18 Dihydromyricetin-3-carboxylic ester and preparation method thereof Pending CN101492439A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910037329 CN101492439A (en) 2009-02-18 2009-02-18 Dihydromyricetin-3-carboxylic ester and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910037329 CN101492439A (en) 2009-02-18 2009-02-18 Dihydromyricetin-3-carboxylic ester and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101492439A true CN101492439A (en) 2009-07-29

Family

ID=40923248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910037329 Pending CN101492439A (en) 2009-02-18 2009-02-18 Dihydromyricetin-3-carboxylic ester and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101492439A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103549154A (en) * 2013-11-11 2014-02-05 天津盛康源生物科技发展有限公司 Application of dihydromyricetin laurate as feed additive
CN110693872A (en) * 2019-10-24 2020-01-17 贵州省生物研究所 Dihydromyricetin with broad-spectrum anti-tumor activity, derivative and application thereof
CN114807262A (en) * 2022-05-25 2022-07-29 江南大学 Dihydromyricetin acylated derivative and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103549154A (en) * 2013-11-11 2014-02-05 天津盛康源生物科技发展有限公司 Application of dihydromyricetin laurate as feed additive
CN103549154B (en) * 2013-11-11 2015-02-18 天津盛康源生物科技发展有限公司 Application of dihydromyricetin laurate as feed additive
CN110693872A (en) * 2019-10-24 2020-01-17 贵州省生物研究所 Dihydromyricetin with broad-spectrum anti-tumor activity, derivative and application thereof
CN114807262A (en) * 2022-05-25 2022-07-29 江南大学 Dihydromyricetin acylated derivative and preparation method thereof
CN114807262B (en) * 2022-05-25 2023-07-25 江南大学 Dihydromyricetin acylated derivative and preparation method thereof

Similar Documents

Publication Publication Date Title
El-Abbassi et al. Phenolic profile and antioxidant activities of olive mill wastewater
Tanaka et al. Synthesis of theaflavin from epicatechin and epigallocatechin by plant homogenates and role of epicatechin quinone in the synthesis and degradation of theaflavin
Bernini et al. Synthesis and structure/antioxidant activity relationship of novel catecholic antioxidant structural analogues to hydroxytyrosol and its lipophilic esters
Fki et al. The use of polyphenolic extract, purified hydroxytyrosol and 3, 4-dihydroxyphenyl acetic acid from olive mill wastewater for the stabilization of refined oils: a potential alternative to synthetic antioxidants
Hashimoto et al. Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols
Tadolini et al. Resveratrol inhibition of lipid peroxidation
Zhou et al. Extraction and antioxidant property of polyhydroxylated naphthoquinone pigments from spines of purple sea urchin Strongylocentrotus nudus
Mukai et al. Structure–activity relationship of the tocopherol-regeneration reaction by catechins
Sang et al. Chemical studies of the antioxidant mechanism of tea catechins: radical reaction products of epicatechin with peroxyl radicals
Mukai et al. Kinetic study of free-radical-scavenging action of flavonoids in homogeneous and aqueous triton X-100 micellar solutions
Lu et al. Enzymatic modification by tannase increases the antioxidant activity of green tea
Miliauskas et al. Antioxidative activity of Geranium macrorrhizum
CN104523442B (en) Symwhite-337 lipid nano particle and its production and use
Im Lee et al. Chromanols from Sargassum siliquastrum and their antioxidant activity in HT 1080 cells
Deiana et al. Wine extracts from Sardinian grape varieties attenuate membrane oxidative damage in Caco-2 cell monolayers
CN101492439A (en) Dihydromyricetin-3-carboxylic ester and preparation method thereof
Sørensen et al. Lipophilization of dihydrocaffeic acid affects its antioxidative properties in fish‐oil‐enriched emulsions
Abramovič Antioxidant properties of hydroxycinnamic acid derivatives: A focus on biochemistry, physicochemical parameters, reactive species, and biomolecular interactions
CN101781340A (en) Purification method of sucrose fatty acid ester
Stebbins et al. Ascorbic acid-catalyzed degradation of cyanidin-3-O-β-glucoside: Proposed mechanism and identification of a novel hydroxylated product
Karpinska et al. A mystery of a cup of coffee; an insight look by chemist
Bernini et al. Chemoselective C-4 aerobic oxidation of catechin derivatives catalyzed by the trametes villosa laccase/1-hydroxybenzotriazole system: Synthetic and mechanistic aspects
Yunxiao et al. Enrichment, analysis, identification and mechanism of antioxidant components in Toona sinensis
Fukasawa et al. Anti-oxidative effects of rooibos tea extract on autoxidation and thermal oxidation of lipids
CN102727536B (en) Metasequoia glyptostroboides bark extract, preparation method thereof and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20090729